Piramal Pharma Solutions

Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO), offering end-to-end development and manufacturing solutions across the drug life cycle. We serve our clients through a globally integrated network of facilities in North America, Europe and Asia. This enables us to offer a comprehensive range of services including drug discovery solutions, process & pharmaceutical development services, clinical trial supplies, commercial supply of APIs and finished dosage forms. We also offer specialized services such as development and manufacture of highly potent APIs, antibody drug conjugation, sterile fill/finish with and without containment, and potent solid oral drug product. Our capability as an integrated service provider & experience with various technologies enables us to serve innovator and generic companies worldwide.

Visit website


We offer Pharmaceutical Development and Manufacturing solutions through collaborative partnership models and we work with our customers throughout the drug life cycle.

We have created a vast network of Development and Manufacturing facilities located in North America, Europe and Asia that offers a multitude of services covering the entire drug life cycle, from Drug Discovery & Development to Commercial Manufacturing of off-patent Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs). Our capability as an integrated service provider & experience with various technologies enables us to serve Innovator and Generic companies worldwide.

Our Development centers & Manufacturing sites have accreditations from regulatory bodies in US, Europe & Japan. With a pool of 450 scientists, including 100 Ph.d’s across the Globe we are committed to Research & Development programs. We offer specialized services such as Antibody Drug Conjugation and are well versed in technologies such as Bio-catalysis.

At Piramal Solutions, we are moving towards becoming a ‘Customer Centric’ organization by focusing on the “Pulse of the Customer”. We are evaluating various ways to improve our internal processes, communications, and program management in order to improve our delivery commitments and service levels.

This division features among the top 10 contract drug manufacturers in the world as per report released by UN Conference on Trade and Development and recently in March 2014 we won two awards for “Quality” and “Reliability” in the CRO/CMO by Life Science Leaders.

Activities include:

  • Drug Discovery Solutions
  • Process R&D
  • Pharmaceutical Development Services
  • Clinical Trial Supplies Services
  • Commercial Manufacturing  of APIs
  • Commercial Manufacturing of Formulations

Direct from the C-Suite- John Fowler, COO, Piramal Pharma Solutions on Supply Chain

Direct from the C-Suite-Stu Needleman, CCO & Chief Patient Centricity Officer on Personal Connection

Direct from the C-Suite - Peter DeYoung, CEO, Piramal Global Pharma on Covid-19, The Challenge

Related Content